{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T22:32:51Z","timestamp":1788561171566,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Head Neck Oncol"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cancer of the parotid gland is relatively rare, but carries poor prognosis owing to its prevailing distant metastases. In addition to the disease's basic epidemiology and pathology, we review some current discoveries of its tumorigenesis molecular mechanism. Based on published salivary gland cancer clinical trial data, non-surgical antitumor efficacies amongst a range of chemotherapy, radiation, and concurrent therapy regimens are compared. We also present the current development status of novel radiation therapy and targeted therapeutics, focusing on intensity-modulated radiation therapy (IMRT), and epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) blockages, which are showing promise for improving parotid gland cancer management.<\/jats:p>","DOI":"10.1186\/1758-3284-3-40","type":"journal-article","created":{"date-parts":[[2011,9,15]],"date-time":"2011-09-15T10:34:53Z","timestamp":1316082893000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["An overview of the rare parotid gland cancer"],"prefix":"10.1186","volume":"3","author":[{"given":"Kimberley","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K","family":"Ann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiguo G","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,9,14]]},"reference":[{"key":"218_CR1","volume-title":"Splanchnology, Section 2a. The Mouth","author":"H Gray","year":"2000","unstructured":"Gray H: Anatomy of the Human Body. Splanchnology, Section 2a. The Mouth. 2000, Philadelphia: Lea & Febiger, 1918; Bartleby.com, Chapter 11: Last accessed 26th July 2011, [http:\/\/www.bartleby.com\/107\/illus1024.html]"},{"key":"218_CR2","volume-title":"SEER Cancer Statistics Review, 1975-2006, National Cancer Institute. Bethesda, MD","year":"2009","unstructured":"Horner MJ, Ries LAG, Krapcho M, (eds), et al: SEER Cancer Statistics Review, 1975-2006, National Cancer Institute. Bethesda, MD. 2009, Last accessed 26th July 2011, [http:\/\/seer.cancer.gov\/csr\/1975_2006\/index.html]"},{"key":"218_CR3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/hed.2890100504","volume":"10","author":"MR Spitz","year":"1988","unstructured":"Spitz MR, Sider JG, Newell GR, Batsakis JG: Incidence of salivary gland cancer in the United States relative to ultraviolet radiation exposure. Head Neck Surg. 1988, 10: 205-308.","journal-title":"Head Neck Surg"},{"key":"218_CR4","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program http:\/\/www.seer.cancer.gov SEER*Stat Database: Incidence - SEER 17 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2010 Sub (2000-2008), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2011, based on the November 2010 submission. http:\/\/seer.cancer.gov\/canques\/incidence.html, http:\/\/canques.seer.cancer.gov\/cgi-bin\/cq_submit?dir=seer2008&db=6&rpt=TAB&sel=^0^4^0^0^^0&y=Sex^1,2&z=Statistic%20type^1,2,3&dec=2,2,2&template=null Last accessed 26th July 2011"},{"key":"218_CR5","unstructured":"Salivary Gland Cancer Detailed Guide. Learn About Cancer from the American Cancer Society. Last accessed 26th July 2011, [http:\/\/www.cancer.org\/Cancer\/SalivaryGlandCancer\/DetailedGuide\/salivary-gland-cancer-what-is-key-statistics]"},{"key":"218_CR6","first-page":"1283","volume-title":"Rubin's Pathology: Clinicopathologic Foundations of Medicine","year":"2004","unstructured":"Rubin R, Strayer DS, (eds): Rubin's Pathology: Clinicopathologic Foundations of Medicine. 2004, Lippincott Williams & Wilkins, Maryland, 1283-85. 4","edition":"4"},{"key":"218_CR7","volume-title":"Clinical Manual of Otolaryngology","author":"TM Davidson","year":"1992","unstructured":"Davidson TM: Clinical Manual of Otolaryngology. 1992, University of California Medical School, San Diego, California, Copyright 2006 Regents University of California. Formerly published under the title Clinical Manual of Otolaryngology, McGraw-Hill Inc, Last accessed 26th July 2011, [http:\/\/drdavidson.ucsd.edu\/Portals\/0\/CMO\/CMO_index.htm]3","edition":"3"},{"key":"218_CR8","unstructured":"Salivary Gland Cancer Overview. Learn About Cancer from the American Cancer Society. Last accessed 26th July 2011, [http:\/\/www.cancer.org\/Cancer\/SalivaryGlandCancer\/OverviewGuide\/salivary-gland-cancer-overview-survival-rates]"},{"key":"218_CR9","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1002\/(SICI)1097-0142(19970415)79:8<1465::AID-CNCR4>3.0.CO;2-A","volume":"79","author":"T Saku","year":"1997","unstructured":"Saku T, Hayashi Y, Takahara O, et al: Salivary gland tumors among atomic bomb survivors, 1950-1987. Cancer. 1997, 79: 1465-75. 10.1002\/(SICI)1097-0142(19970415)79:8<1465::AID-CNCR4>3.0.CO;2-A.","journal-title":"Cancer"},{"key":"218_CR10","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1002\/1097-0142(19841101)54:9<1854::AID-CNCR2820540915>3.0.CO;2-1","volume":"54","author":"MR Spitz","year":"1984","unstructured":"Spitz MR, Tilley BC, Batsakis JG, Gibeau JM, Newell GR: Risk factors for major salivary gland carcinoma: a case-comparison study. Cancer. 1984, 54: 1854-1859. 10.1002\/1097-0142(19841101)54:9<1854::AID-CNCR2820540915>3.0.CO;2-1.","journal-title":"Cancer"},{"key":"218_CR11","doi-asserted-by":"publisher","first-page":"160","DOI":"10.7326\/0003-4819-87-2-160","volume":"87","author":"AB Schneider","year":"1977","unstructured":"Schneider AB, Favus MJ, Stachura ME: Salivary gland neoplasms as a late consequence of head and neck irradiation. Ann Intern Med. 1977, 87: 160-164.","journal-title":"Ann Intern Med"},{"issue":"4","key":"218_CR12","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1097\/00001648-199707000-00011","volume":"8","author":"PL Horn-Ross","year":"1997","unstructured":"Horn-Ross PL, Ljung BM, Morrow M: Environmental factors and the risk of salivary gland cancer. Epidemiology. 1997, 8 (4): 414-419. 10.1097\/00001648-199707000-00011.","journal-title":"Epidemiology"},{"key":"218_CR13","first-page":"333","volume":"12","author":"TF Mancuso","year":"1970","unstructured":"Mancuso TF, Brennan MJ: Epidemiological considerations of cancer of the gallbladder, bile ducts and salivary glands in the rubber industry. Journal of Occup Med. 1970, 12: 333-341.","journal-title":"Journal of Occup Med"},{"issue":"1","key":"218_CR14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3322\/canjclin.34.1.24","volume":"34","author":"RJ McKenna","year":"1984","unstructured":"McKenna RJ: Tumors of the major and minor salivary glands. CA Cancer J Clin. 1984, 34 (1): 24-39. 10.3322\/canjclin.34.1.24.","journal-title":"CA Cancer J Clin"},{"key":"218_CR15","volume-title":"Current diagnosis & treatment in otolaryngology: head & neck surgery","author":"Anil K Lalwani","year":"2008","unstructured":"Lalwani Anil: Malignant Diseases of the Salivary Glands. Current diagnosis & treatment in otolaryngology: head & neck surgery. 2008, McGraw-Hill Medical, Chapter 18:"},{"issue":"20","key":"218_CR16","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1038\/sj.emboj.7600818","volume":"24","author":"A Scott","year":"2005","unstructured":"Scott A, Chung H, Gonciarz-Swiatek M, et al: Structural and mechanistic studies of VPS4 proteins. The European Molecular Biology Organization Journal. 2005, 24 (20): 3658-3668.","journal-title":"The European Molecular Biology Organization Journal"},{"key":"218_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0092-8674(00)00114-8","volume":"103","author":"J Schlessinger","year":"2000","unstructured":"Schlessinger J: Cell signaling by receptor tyrosine kinases. Cell. 2000, 103: 211-225. 10.1016\/S0092-8674(00)00114-8.","journal-title":"Cell"},{"key":"218_CR18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0092-8674(00)00100-8","volume":"103","author":"MA Simon","year":"2000","unstructured":"Simon MA: Receptor tyrosine kinases: specific outcomes from general signals. Cell. 2000, 103: 13-15. 10.1016\/S0092-8674(00)00100-8.","journal-title":"Cell"},{"key":"218_CR19","doi-asserted-by":"crossref","unstructured":"Li E, Hristova K: Role of receptor tyrosine kinase transmembrane domains in cell signaling and human pathologies. Biochemistry. 45 (20): 6241-51.","DOI":"10.1021\/bi060609y"},{"key":"218_CR20","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/nrm883","volume":"3","author":"A Sorkin","year":"2002","unstructured":"Sorkin A, Von Zastrow M: Signal transduction and endocytosis: close encounters of many kinds. Nut Rev Mol Cell Biol. 2002, 3: 600-614. 10.1038\/nrm883.","journal-title":"Nut Rev Mol Cell Biol"},{"key":"218_CR21","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/nrm973","volume":"3","author":"DJ Katzmann","year":"2002","unstructured":"Katzmann DJ, Odorizzi G, Emr SD: Receptor downregulation and multivesicular-body sorting. Nut Rev Mol Cell Biol. 2002, 3: 893-905. 10.1038\/nrm973.","journal-title":"Nut Rev Mol Cell Biol"},{"key":"218_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/978-3-642-00302-8_2","volume":"335","author":"A Esclatine","year":"2009","unstructured":"Esclatine A, Chaumorcel M, Codogno P: Macroautophagy signaling and regulation. Curr Top Microbiol Immunol. 2009, 335: 33-70. 10.1007\/978-3-642-00302-8_2.","journal-title":"Curr Top Microbiol Immunol"},{"key":"218_CR23","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1111\/j.1600-0854.2007.00642.x","volume":"8","author":"SR White","year":"2007","unstructured":"White SR, Lauring B: AAA+ ATPases: achieving diversity of function with conserved machinery. Traffic. 2007, 8: 1657-1667. 10.1111\/j.1600-0854.2007.00642.x.","journal-title":"Traffic"},{"key":"218_CR24","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1126\/science.290.5497.1717","volume":"290","author":"DJ Klionsky","year":"2000","unstructured":"Klionsky DJ, Emr SD: Autophagy as a regulated pathway of cellular degradation. Science. 2000, 290: 1717-1721.","journal-title":"Science"},{"key":"218_CR25","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1016\/j.cub.2007.09.032","volume":"17","author":"TE Rusten","year":"2007","unstructured":"Rusten TE, Vaccari T, Lindmo K: ESCRTs and Fabl regulate distinct steps of autophagy. Curr Biol. 2007, 17: 1817-1825. 10.1016\/j.cub.2007.09.032.","journal-title":"Curr Biol"},{"key":"218_CR26","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/j.febslet.2009.12.034","volume":"584","author":"N Chen","year":"2010","unstructured":"Chen N, Debnath J: Autophagy and tumorigenesis. Federation of European Biochemical Societies Letters. 2010, 584: 1427-1435. 10.1016\/j.febslet.2009.12.034.","journal-title":"Federation of European Biochemical Societies Letters"},{"key":"218_CR27","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nrc2771","volume":"10","author":"T Santarius","year":"2010","unstructured":"Santarius T, Shipley J, Brewer D: A census of amplified and overexpressed human cancer genes. Nut Rev Cancer. 2010, 10: 59-64. 10.1038\/nrc2771.","journal-title":"Nut Rev Cancer"},{"issue":"2","key":"218_CR28","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/0360-3016(93)90233-L","volume":"27","author":"GE Laramore","year":"1993","unstructured":"Laramore GE, Krall JM, Griffin TW, et al: Neutron versus photon irradiation for unresectable salivary gland tumors: Final report of an RTOG-MRC randomized clinical trial. Radiation Therapy Oncology Group. Medical Research Council. Int J Radiat Oncol Biol Phys. 1993, 27 (2): 235-240. 10.1016\/0360-3016(93)90233-L.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"218_CR29","first-page":"275","volume":"33","author":"KJ Stelzer","year":"1994","unstructured":"Stelzer KJ, Laramore GE, Griffin TW, et al: Fast neutron radiotherapy. The University of Washington experience. Acta Oncol. 1994, 33 (3): 275-80.","journal-title":"The University of Washington experience. Acta Oncol"},{"issue":"2","key":"218_CR30","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0167-8140(00)00273-5","volume":"59","author":"PE Huber","year":"2001","unstructured":"Huber PE, Debus J, Latz D, et al: Radiotherapy for advanced adenoid cystic carcinoma: neutrons, photons or mixed beam?. Radiother Oncol. 2001, 59 (2): 161-7. 10.1016\/S0167-8140(00)00273-5.","journal-title":"Radiother Oncol"},{"issue":"17","key":"218_CR31","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1200\/JCO.2005.05.3025","volume":"24","author":"SA Laurie","year":"2006","unstructured":"Laurie SA, Licitra L: Systemic therapy in the palliative management of advanced salivary gland cancers. J Clin Oncol. 2006, 24 (17): 2673-8. 10.1200\/JCO.2005.05.3025.","journal-title":"J Clin Oncol"},{"issue":"3","key":"218_CR32","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/1097-0142(20010201)91:3<541::AID-CNCR1032>3.0.CO;2-Y","volume":"91","author":"M Airoldi","year":"2001","unstructured":"Airoldi M, Pedani F, Succo G, et al: Phase II randomized trial comparing vinorelbine versus vinorelbine plus cisplatin in patients with recurrent salivary gland malignancies. Cancer. 2001, 91 (3): 541-7. 10.1002\/1097-0142(20010201)91:3<541::AID-CNCR1032>3.0.CO;2-Y.","journal-title":"Cancer"},{"key":"218_CR33","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1002\/1097-0142(19911101)68:9<1874::AID-CNCR2820680904>3.0.CO;2-S","volume":"68","author":"L Licitra","year":"1991","unstructured":"Licitra L, Marchini S, Spinazz\u00e8 S, et al: Cisplatin in advanced salivary gland carcinoma. A phase II study of 25 patients. Cancer. 1991, 68: 1874-1877. 10.1002\/1097-0142(19911101)68:9<1874::AID-CNCR2820680904>3.0.CO;2-S.","journal-title":"Cancer"},{"issue":"3","key":"218_CR34","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/hed.20327","volume":"28","author":"J Gilbert","year":"2006","unstructured":"Gilbert J, Li Y, Pinto HA, Jennings T, et al: Phase II trial of taxol in salivary gland malignancies (E1394): a trial of the Eastern Cooperative Oncology Group. Head Neck. 2006, 28 (3): 197-204. 10.1002\/hed.20327.","journal-title":"Head Neck"},{"issue":"5","key":"218_CR35","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/00001813-200206000-00007","volume":"13","author":"C Gedlicka","year":"2002","unstructured":"Gedlicka C, Sch\u00fcll B, Formanek M, et al: Mitoxantrone and cisplatin in recurrent and\/or metastatic salivary gland malignancies. Anticancer Drugs. 2002, 13 (5): 491-5. 10.1097\/00001813-200206000-00007.","journal-title":"Anticancer Drugs"},{"key":"218_CR36","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1002\/1097-0142(19871215)60:12<2869::AID-CNCR2820601203>3.0.CO;2-Y","volume":"60","author":"AI Dreyfuss","year":"1987","unstructured":"Dreyfuss AI, Clark JR, Fallon BG, Posner MR, Norris CM, Miller D: Cyclophosphamide, doxorubicin, and cisplatin combination chemotherapy for advanced carcinomas of salivary gland origin. Cancer. 1987, 60: 2869-2872. 10.1002\/1097-0142(19871215)60:12<2869::AID-CNCR2820601203>3.0.CO;2-Y.","journal-title":"Cancer"},{"issue":"4","key":"218_CR37","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/1097-0142(19810215)47:4<645::AID-CNCR2820470404>3.0.CO;2-A","volume":"47","author":"DS Alberts","year":"1981","unstructured":"Alberts DS, Manning MR, Coulthard SW, Koopmann CF, Herman TS: Adriamycin\/cis-platinum\/Cyclophosphamide Combination Chemotherapy for Advanced Carcinoma of the Parotid Gland. Cancer. 1981, 47 (4): 645-8. 10.1002\/1097-0142(19810215)47:4<645::AID-CNCR2820470404>3.0.CO;2-A.","journal-title":"Cancer"},{"issue":"2","key":"218_CR38","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S1741-9409(03)00003-7","volume":"40","author":"JD Raguse","year":"2004","unstructured":"Raguse JD, Gath HJ, Bier J, Riess H, Oettle H: Docetaxel (Taxotere) in recurrent high grade mucoepidermoid carcinoma of the major salivary glands. Oral Oncol. 2004, 40 (2): 5-7.","journal-title":"Oral Oncol"},{"key":"218_CR39","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1200\/JCO.2005.05.2829","volume":"24","author":"DM Brizel","year":"2006","unstructured":"Brizel DM, Esclamado R: Concurrent chemoradiotherapy for locally advanced nonmetastatic, squamous carcinoma of the head and neck: consensus, controversy, and conundrum. J Clin Oncol. 2006, 24: 2612-2617. 10.1200\/JCO.2005.05.2829.","journal-title":"J Clin Oncol"},{"key":"218_CR40","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u2122). Head and Neck Cancers. Version 1.2011. NCCN.org. 2011, National Comprehensive Cancer Network. lnc, Last accessed 26th July 2011, [http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/head-and-neck.pdf]"},{"key":"218_CR41","volume-title":"American Joint Committee on Cancer (AJCC): AJCC Cancer Staging Manual","year":"2010","unstructured":"Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, (eds): American Joint Committee on Cancer (AJCC): AJCC Cancer Staging Manual. 2010, New York, Berlin, Heidelberg: Springer-Verlag, 7","edition":"7"},{"issue":"4","key":"218_CR42","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.ijrobp.2010.05.012","volume":"79","author":"TA van de Water","year":"2011","unstructured":"van de Water TA, Lomax AJ, Bijl HP, et al: Potential benefits of scanned intensity-modulated proton therapy versus advanced photon therapy with regard to sparing of the salivary glands in oropharyngeal cancer. Int J Radiat Oncol Biol Phys. 2011, 79 (4): 1216-24. 10.1016\/j.ijrobp.2010.05.012. Epub 2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"218_CR43","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S1470-2045(09)70311-0","volume":"11","author":"JA Bonner","year":"2010","unstructured":"Bonner JA, Harari PM, Giralt J, et al: Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomized trial, and relation between cetuximab-induced rash and survival. Lancet Oncol. 2010, 11 (1): 21-8. 10.1016\/S1470-2045(09)70311-0. Epub 2009","journal-title":"Lancet Oncol"},{"issue":"3","key":"218_CR44","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S1470-2045(09)70002-6","volume":"10","author":"EE Cohen","year":"2009","unstructured":"Cohen EE, Davis DW, Karrison TG, et al: A phase II study erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck. Lancet Oncol. 2009, 10 (3): 247-57. 10.1016\/S1470-2045(09)70002-6.","journal-title":"Lancet Oncol"},{"issue":"4","key":"218_CR45","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1080\/00016480500401035","volume":"126","author":"I Schwentner","year":"2006","unstructured":"Schwentner I, Obrist P, Thumfart W, Sprinzl G: Distant metastasis of parotid gland tumors. Acta Otolaryngol. 2006, 126 (4): 340-5. 10.1080\/00016480500401035.","journal-title":"Acta Otolaryngol"}],"container-title":["Head &amp; Neck Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1758-3284-3-40.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T16:25:29Z","timestamp":1712852729000},"score":1,"resource":{"primary":{"URL":"https:\/\/headandneckoncology.biomedcentral.com\/articles\/10.1186\/1758-3284-3-40"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,14]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["218"],"URL":"https:\/\/doi.org\/10.1186\/1758-3284-3-40","relation":{},"ISSN":["1758-3284"],"issn-type":[{"value":"1758-3284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,14]]},"assertion":[{"value":"18 August 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"40"}}